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Abstract
Background: The adult population in Sri Lanka is having high level of susceptibility for Varicella Zoster Virus (VZV) 
infection. Among medical undergraduates, 47% are VZV seronegative. The purpose of the present study was to 
determine the incidence of VZV infection in medical undergraduates in Sri Lanka, and to describe the effects of VZV 
infection on their academic activities.
Methods: A retrospective cohort of medical undergraduates' susceptible for VZV infection was selected from the 
University of Peradeniya, Sri Lanka. Data on the incidence of VZV infection (Chickenpox) during their undergraduate 
period was collected using a self-administered structured questionnaire. A second questionnaire was administered to 
collect data on the details of VZV infection and the impact of it on their academic activities. VZV incidence rate was 
calculated as the number of infections per 1,000 person years of exposure. Descriptive statistics were used to describe 
the impact of VZV infection on academic activities.
Results: Out of the 172 susceptible cohort, 153 medical undergraduates were followed up. 47 students reported VZV 
infection during the follow up period and 43 of them participated in the study. The cumulative incidence of VZV 
infection during the period of five and half years of medical training was 30.7%. Incidence density of VZV infection 
among medical undergraduates in this cohort was 65.1 per 1,000 person years of follow-up. A total of 377 working days 
were lost by 43 students due to the VZV infection, averaging 8.8 days per undergraduate. Total academic losses for the 
study cohort were; 205 lectures, 17 practicals, 13 dissection sessions, 11 tutorials, 124 days of clinical training and 107 
days of professorial clinical appointments. According to their perception they lost 1,927 study hours due to the illness 
(Median 50 hours per undergraduate).
Conclusions: The incidence of VZV infection among Sri Lankan medical undergraduates is very high and the impact of 
this infection on academic activities causes severe disruption of their undergraduate life. VZV immunization for 
susceptible new entrant medical undergraduates is recommended.
Background
Sero-epidemiological reports[1-3] and reports from the
Infectious Disease Hospital[4] in Sri Lanka demonstrate
strong evidence of a high level of susceptibility for Vari-
cella Zoster Virus (VZV) infection among the adult pop-
ulation in Sri Lanka. According to the Indoor Morbidity
and Mortality Report (IMMR) in 2003, 1,749 patients
with VZV infection were admitted to government hospi-
tals in Sri Lanka, out of which 15 were fatal[5]. Disease
outbreaks have been frequently reported from institu-
tional settings, but data are not available on these out-
breaks. Even though these reports are suggestive of high
susceptibility, accurate morbidity and mortality data on
VZV infection is scarce in Sri Lanka. In 2006, VZV infec-
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tion was made a notifiable disease in Sri Lanka[6] and the
Epidemiology Unit launched a passive surveillance sys-
tem in order to provide baseline data on VZV morbidity.
In 2007, the total number of notifications received by the
Epidemiology Unit was 3,435[7]. This number increased
by 59.5% by 2008, with 5,493 patients contacting VZV
infection[8]. In a tropical country with a population of 20
million, this is an under estimate of the actual incidence
of VZV infection. Further, it does not provide data on
high-risk groups. The true incidence rate, which is of
utmost importance in determining high-risk groups and
generating vaccination policies is yet to be described for
Sri Lanka.
In 1995, the United States of America introduced the
VZV vaccine to their National Immunization Program [9]
which was followed by several other countries in the
western world. The epidemiology of VZV infection in
these countries had changed drastically with the intro-
duction of the vaccine[10]. In most of the countries in the
South Asian region including Sri Lanka, the VZV vaccine
is not included in the National Immunization Programs
at present. In Sri Lanka, it is available in pro-profit private
sector providers. Even in the private sector, the use of the
VZV vaccine was very low according to a study done in
C o l o m b o ,  S r i  L a n k a .  T h e y  r e p o r t e d  t h a t  o n l y  4 . 2 %  o f
children less than three years were immunized with VZV
vaccine[11]. At present, the immunity to the disease is
acquired by contracting the natural infection in a large
proportion of the population.
Health care workers have long been identified as a high
risk group for VZV infection [12]. Most of the developed
countries have well defined vaccine policies for health-
care workers and institutional policies for undergraduates
in health care settings [13-17]. Susceptibility of medical
undergraduates to common infectious diseases has been
studied widely and findings of these studies provide
strong evidence to support these vaccination policies [18-
21]. In 2008, it was reported that the susceptible propor-
tion of medical undergraduates for VZV infection was as
high as 47% in Sri Lanka [1]. Nevertheless, further data
are required to make policy decisions regarding the dis-
ease incidence and the impact of VZV infection among
medical undergraduates on their academic activities. The
present study was conducted to determine the incidence
of VZV infection in medical undergraduates in Sri Lanka,
and to describe the effects of VZV infection on their aca-
demic activities.
Methods
In the years 2002 and 2003, Faculty of Medicine, Univer-
sity of Peradeniya, Sri Lanka conducted a sero-epidemio-
logical study to estimate the susceptibility of new-entrant
university undergraduates to VZV infection. Undergrad-
uates entering the Faculties of Medicine and Engineering
during the period of 2002 and 2003 were invited to par-
ticipate in this study. Findings of this sero-epidemiologi-
cal study and the methodology was published elsewhere
[1]. We used the susceptibility data of medical undergrad-
uates of this sero-epidemiological study for the present
study.
The present study was conducted as a retrospective
cohort study. A cohort of medical undergraduates' sus-
ceptible for VZV infection were selected from the previ-
ous study [1] using the following methodology. First, all
medical undergraduates with a positive history of VZV
infection were excluded from the study sample, and the
remaining medical undergraduates underwent a VZV
antibody test (anti-VZV antibody IgM ELISA kit-Human
Diagnostics, Germany). All the VZV antibody negative
medical undergraduates were selected as the susceptible
cohort (study sample) for the present study.
The susceptible (VZV antibody negative) cohort of
medical undergraduates was contacted after their final
examination to collect data for the present study. Data on
the incidence of VZV infection during their undergradu-
ate period was collected using a self-administered struc-
tured questionnaire. Self reported history of VZV
infection was used as a valid measure of VZV infection in
this study. For those who reported a history of VZV infec-
tion during the study period, a second self administered
structured questionnaire was used to collect data on the
details of their VZV infection and to measure the impact
of it on their academic activities. The month and the year
of acquiring the infection was used to calculate the period
at risk in months for each participant. All who acquired
the disease were removed subsequently from the at risk
population to calculate the incidence density of VZV
infection. Details on the duration of staying away from
studies, effect of the infection on their academic activities
and impact on examinations were obtained from this
questionnaire.
Data was analysed using SPSS 13 statistical software.
Incidence rate was calculated as the number of infections
per 1,000 person years of exposure. Total person years of
exposure was calculated using the exact period at risk.
Once a student is infected, he/she is not at risk anymore
and time spent as undergraduate after the infection was
not included in the denominator. In this calculation, each
student who has not had VZV during the undergraduate
period contributed by 5.5 years, whereas students who
had VZV contributed less. Descriptive statistics were
used to describe the impact of VZV infection on aca-
demic activities. Ethical clearance for the study was
obtained from the Ethical Review Committee, Faculty of
Medicine, University of Peradeniya, Sri Lanka.Agampodi et al. BMC Infectious Diseases 2010, 10:117
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Results
Figure 1 shows the study flow chart with the number of
medical undergraduates followed-up in each step of the
study. The initial susceptible study cohort consisted of
172 (89 males and 83 females) undergraduates from two
batches of entrants entering the Faculty of Medicine, Uni-
versity of Peradeniya, Sri Lanka in 2002 and 2003. We
could only follow-up 153 susceptible and the proportion
lost to follow up was 11.0%.
During a period of five and a half years, 47 medical
undergraduates had VZV infection, which accounted for
30.7% cumulative incidence of VZV infection during
their undergraduate period. The total person years of
exposure were 722. Incidence density of VZV infection
among medical undergraduates in this cohort was 65.1
per 1,000 person years of follow-up. Figure 2 illustrate the
cumulative incidence of VZV infection calculated in this
study.
Of the 47 medical undergraduates who had VZV infec-
tion, 43 completed the second questionnaire (response
rate - 91.5%). Table 1 shows their demographic profile.
The age range of the VZV infected undergraduates was
25 to 28 years. The majority (67.4%0 were males and
belonged to the Sinhalese ethnic group (97.7%). Out of
the 43 medical undergraduates who responded, only
three (7.0%) had moderate to severe complications; two
had pneumonia and the other had a widespread second-
ary bacterial infection. The median duration of fever was
three days with an inter-quartile range of 1-3 days. The
majority, (88.4%) were residing outside their homes (in a
university hostel or a boarding place) when they devel-
oped the symptomatic disease. Five (11.6%) medical
undergraduates acquired the infection while they were at
home.
Only two (4.6%) were hospitalized during the illness,
and both had VZV pneumonia. All but one went home
for the total duration of their illness. Nine (20.9%) went
home on the second or third day of diagnosis and 27
(62.8%) went home on the same day of diagnosis.
Table 2 shows the academic activities lost due to the
VZV infection. A total of 377 working days were lost by
them, averaging 8.8 days per medical undergraduate.
Total academic losses for the study cohort were; 205 lec-
tures, 17 practical sessions, 13 dissection sessions, 11
tutorials, 124 days of clinical appointments (clinical train-
ing in hospitals in third and fourth years) and 107 days of
professorial appointments (final year clinical training in
Medicine, Surgery, Gynaecology/Obstetrics and Paediat-
ric wards). According to their individual perception, they
lost 1,927 study hours due to the illness. This accounted
for a median of 50 hours (IQ range 28-60) per medical
undergraduate.
Impact of the disease on academic performance and
undergraduate activities is showed in Table 2. Twenty
(46.5%) medical undergraduates thought the disease
reduced their study duration considerably, but did not
affect their performance at examinations. Four (9.3%)
medical undergraduates thought that due to the study
hours lost during VZV infection they could not perform
well at the examination and obtained a general pass with-
out honours. Another four were prevented from sitting
an examination (other than the final examination) due to
the infection and two (4.7%) claimed that they did not
pass because of the infection. Two medical undergradu-
ates (4.7%) could not sit the final examination, which
delayed their internship by six months. Three students
Figure 1 Study flow chart with number loss to follow-up in each 
step.
Figure 2 Cumulative proportion of medical undergraduates with 
VZV infection during the period of 66 months (five and half years 
of undergraduate period).Agampodi et al. BMC Infectious Diseases 2010, 10:117
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who had complications reported similar loss of academic
activities and two of them thought that it affected their
examination performance.
Discussion
This study confirmed that medical undergraduates are a
high-risk population for VZV infection, reporting an
incidence density of 65.1 per 1,000 person years of follow-
up. According to population based studies and surveil-
lance reports from other countries, the incidence of VZV
infection among adults is higher in tropical countries
compared to temperate countries [22]. Nevertheless, the
incidence of more than 50 per 1,000 person years of fol-
low-up is much higher than the rates reported in the pre-
vaccine era in several countries [23-25]. These reported
incidence data do not indicate true incidence, because the
denominator in most of these estimations includes the
immune population, not the susceptible population,
which can severely underestimate the incidence. The
reported incidence for medical undergraduates in Sri
Lanka is very high compared to these other studies [23-
25] even when the difference in the denominator is taken
into account.
This high incidence density is not surprising in the
study population of the present study due to the high
exposure rate among them. Preventing outbreaks in such
a population is impossible without a proper immuniza-
tion policy. The present study shows that at the time of
the diagnosis, 88% of the medical undergraduates were
residing at hostels. Even though most of them went home
on the same day of the diagnosis (27/38, 62.8%), by the
time they were diagnosed, they had enough time to infect
others in these crowded hostels. Most of these hostel
rooms in the study setting are occupied by around 4
undergraduates although they are designed for two. In
addition during lectures, practical sessions, dissection
sessions, tutorials and clinical appointments, the close
contact with a large number of others facilitates the effec-
tive transmission of infection.
The present study further highlights that only two med-
ical undergraduates with complications were admitted to
a health care facility (hospital) for treatment of the infec-
tion. If the others were self diagnosed or diagnosed by
informal examinations by a faculty member, these infec-
tions may not have been reported to the communicable
disease notification system of the country. Therefore, the
actual disease burden estimations based on routine noti-
fication data will not include medical undergraduates as a
high risk group. If this situation also prevails in the gen-
eral population, the reported data will be a severe under-
estimate of the actual disease burden in Sri Lanka.
Susceptible medical undergraduates will start work as
medical officers after the completion of their degree.
Only around 30% of the study cohort was infected during
Table 1: Characteristics of the 43 medical undergraduates who had VZV infection.
Mean age (SD) years 26.7 (0.95)
Sex
Male (%) 29 (67.4)
Female (%) 14 (32.6)
Ethnicity
Sinhalese (%) 42 (97.7)
Tamil (%) 01 (2.3)
Table 2: Perceived effect of VZV infection on academic activities among the 43 medical undergraduates who developed 
the disease during the 66 months of follow-up.
Effect of VZV infection on academic 
activities
N%
No effect on academic activities 6 13.9
Reduced study duration 20 46.5
Repeated a clinical appointment (more 
than 1 week)
51 1 . 6
Could not sit an examination 4 9.3
Reduced performance in examinations 
(passed exams without classes)
49 . 3
Failed one or more subject 2 4.7
Delayed internship 2 4.7Agampodi et al. BMC Infectious Diseases 2010, 10:117
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the follow-up period and more males were infected while
the majority of the females remained susceptible. VZV
infection during adult life and especially during preg-
nancy has been shown to entail severe complications on
the mother and the child [26]. Therefore, there is an
increased risk to these female medical officers who are in
their reproductive age from VZV infection once they
start work.
Further, our study shows that less than 5% of the sus-
ceptible students acquired the infection during the first
20 months where pre-clinical subjects are taught. A very
high percentage (>25%) of students were infected during
the period where they engaged in clinical activities. Some
of the students may have worked in wards where there
were pregnant mothers, elderly patients and immuno-
compromised patients. These patients were at high risk of
acquiring VZV with complications as a hospital acquired
infection.
The effect of VZV infection on academic activities,
which have not been documented previously in Sri
Lanka, shows a huge impact on the life of the individual
medical undergraduate. These factors are difficult to
m e a s u r e  i n  c o s t  e f f e c t i v e  t e r m s.  Y e t,  i t  i s  e v i d e n t  t h a t
immunization programs can have a remarkable effect in
their future, especially for those who could not perform
to their optimum due to the VZV infection.
Currently, most developed countries have immuniza-
tion policies for medical undergraduates [13,15]. The
present Sri Lankan health policy does not include immu-
nization against VZV infection and only two vaccines
(Hepatitis B and Rubella) are given in an ad hoc manner
in some of the universities. Either the National Advisory
Committee on Infectious Diseases or individual universi-
ties should make their decision on an immunization pol-
icy. We recommended including a VZV immunization
policy for medical undergraduates in Sri Lankan medical
schools.
Limitations
This study has several limitations where the interpreta-
tion of results should be done within these limitations.
First, VZV infection was confirmed by recall history of
medical undergraduates, but not by serological evalua-
tion. Recall bias could have affected the study in several
ways. VZV could cause subclinical infections or very mild
clinical disease, where the classical clinical picture is not
apparent. This mild or subclinical infections which was
not diagnosed or was not remembered by the respondent
could underestimate the true incidence of VZV in this
study population. Secondly, respondents may have misdi-
agnosed a rash with fever due to other causes as a mild
case of VZV infection, resulting in an overestimation of
VZV incidence. The study was conducted after the final
year exams and the recall period was 5.5 years. Even
though they could recall major impacts such as failing in
exams, number of lectures/practicals missed could be
affected by the recall bias. To minimise the overestima-
tion, we inquired about the minimum number of classes
missed.
Conclusions
The incidence of VZV infection among medical under-
graduates is very high and the impact of this infection on
academic activities causes severe disruption of an under-
graduate's life which could affect his/her future. The
authors strongly recommend that University health
authorities consider VZV immunization for susceptible
new entrant medical undergraduates/university students
in Sri Lanka.
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